296 related articles for article (PubMed ID: 25415617)
21. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
22. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
23. Exogenous spermine attenuates diabetic kidney injury in rats by inhibiting AMPK/mTOR signaling pathway.
Zhang X; Zhang L; Chen Z; Li S; Che B; Wang N; Chen J; Xu C; Wei C
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33537831
[TBL] [Abstract][Full Text] [Related]
24. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
25. Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway.
Huang G; Zou B; Lv J; Li T; Huai G; Xiang S; Lu S; Luo H; Zhang Y; Jin Y; Wang Y
Int J Mol Med; 2017 Mar; 39(3):559-568. PubMed ID: 28112381
[TBL] [Abstract][Full Text] [Related]
26. Role of Ragulator in the Regulation of Mechanistic Target of Rapamycin Signaling in Podocytes and Glomerular Function.
Yao Y; Wang J; Yoshida S; Nada S; Okada M; Inoki K
J Am Soc Nephrol; 2016 Dec; 27(12):3653-3665. PubMed ID: 27032892
[TBL] [Abstract][Full Text] [Related]
27. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury.
Eid AA; Ford BM; Bhandary B; de Cassia Cavaglieri R; Block K; Barnes JL; Gorin Y; Choudhury GG; Abboud HE
Diabetes; 2013 Aug; 62(8):2935-47. PubMed ID: 23557706
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in our understanding of insulin signalling to the podocyte.
Lay A; Coward RJ
Nephrol Dial Transplant; 2014 Jun; 29(6):1127-33. PubMed ID: 24286976
[TBL] [Abstract][Full Text] [Related]
29. mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans.
Puelles VG; van der Wolde JW; Wanner N; Scheppach MW; Cullen-McEwen LA; Bork T; Lindenmeyer MT; Gernhold L; Wong MN; Braun F; Cohen CD; Kett MM; Kuppe C; Kramann R; Saritas T; van Roeyen CR; Moeller MJ; Tribolet L; Rebello R; Sun YB; Li J; Müller-Newen G; Hughson MD; Hoy WE; Person F; Wiech T; Ricardo SD; Kerr PG; Denton KM; Furic L; Huber TB; Nikolic-Paterson DJ; Bertram JF
JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31534053
[TBL] [Abstract][Full Text] [Related]
30. Xuesaitong Protects Podocytes from Apoptosis in Diabetic Rats through Modulating PTEN-PDK1-Akt-mTOR Pathway.
Xue R; Zhai R; Xie L; Zheng Z; Jian G; Chen T; Su J; Gao C; Wang N; Yang X; Xu Y; Gui D
J Diabetes Res; 2020; 2020():9309768. PubMed ID: 32051833
[TBL] [Abstract][Full Text] [Related]
31. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
[TBL] [Abstract][Full Text] [Related]
32. Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.
Li D; Lu Z; Xu Z; Ji J; Zheng Z; Lin S; Yan T
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27129295
[TBL] [Abstract][Full Text] [Related]
33. Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.
Guzman J; Jauregui AN; Merscher-Gomez S; Maiguel D; Muresan C; Mitrofanova A; Diez-Sampedro A; Szust J; Yoo TH; Villarreal R; Pedigo C; Molano RD; Johnson K; Kahn B; Hartleben B; Huber TB; Saha J; Burke GW; Abel ED; Brosius FC; Fornoni A
Diabetes; 2014 Feb; 63(2):701-14. PubMed ID: 24101677
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Exacerbates Podocyte Injury and the Progression of Diabetic Kidney Disease.
Qu H; Gong X; Liu X; Zhang R; Wang Y; Huang B; Zhang L; Zheng H; Zheng Y
Diabetes; 2021 Jun; 70(6):1372-1387. PubMed ID: 33741719
[TBL] [Abstract][Full Text] [Related]
35. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
[TBL] [Abstract][Full Text] [Related]
36. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway.
Sun J; Li ZP; Zhang RQ; Zhang HM
Biochem Biophys Res Commun; 2017 Jan; 483(1):318-324. PubMed ID: 28017719
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
[TBL] [Abstract][Full Text] [Related]
38. Regulation of podocytes function by AMP-activated protein kinase.
Rogacka D; Audzeyenka I; Piwkowska A
Arch Biochem Biophys; 2020 Oct; 692():108541. PubMed ID: 32781053
[TBL] [Abstract][Full Text] [Related]
39. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
40. Podocytes, glucose and insulin.
Welsh GI; Coward RJ
Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):379-84. PubMed ID: 20539231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]